Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nathan, S. S.
Right arrow Articles by Healey, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nathan, S. S.
Right arrow Articles by Healey, J. H.
Clinical Cancer Research Vol. 11, 2389-2397, March 2005
© 2005 American Association for Cancer Research


Cancer Therapy: Preclinical

Elevated Physiologic Tumor Pressure Promotes Proliferation and Chemosensitivity in Human Osteosarcoma

Saminathan S. Nathan1, Gene R. DiResta1, Jorge E. Casas-Ganem1, Bang H. Hoang1, Rebecca Sowers2, Rui Yang2, Andrew G. Huvos3, Richard Gorlick2 and John H. Healey1

1 Orthopaedic Surgery Service, Department of Surgery, and Departments of 2 Pediatrics and 3 Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York

Requests for reprints: John H. Healey, Orthopaedic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, Suite A342, 1275A York Avenue, New York, NY 10021. Phone: 212-639-7610; Fax: 212-794-4015; E-mail: healeyj{at}mskcc.org.

Purpose: This study investigates the effect of constitutively raised interstitial fluid pressure on osteosarcoma physiology and chemosensitivity.

Experimental Design: We did pressure and blood flow assessments at the time of open biopsy in patients with the diagnosis of high-grade osteosarcoma and correlated this to survival and chemotherapy-associated tumor necrosis. Osteosarcoma cell lines were then evaluated for proliferative and therapeutic indices in a replicated high-pressure environment.

Results: Sixteen osteosarcomas in vivo were assessed and exhibited elevated interstitial fluid pressures (mean 35.2 ± SD, 18.6 mmHg). This was not associated with significantly impeded blood flow as measured by a Doppler probe at a single site (P < 0.12). Nonetheless, greater chemotherapy-associated necrosis and associated longer survival were seen in tumors with higher interstitial fluid pressures (P < 0.05).

In vitro, cells undergo significant physiologic changes under pressure. Osteosarcoma cell lines grown in a novel hydrostatically pressurized system had variable cell line–specific growth proportional to the level of pressure. They were more proliferative as indicated by cell cycle analysis with more cells in S phase after 48 hours of pressurization (P < 0.01). There was a significant elevation in the cell cycle–related transcription factors E2F-1 (P < 0.03) and E2F-4 (P < 0.002). These changes were associated with increased chemosensitivity. Cells tested under pressure showed an increased sensitivity to cisplatin (P < 0.00006) and doxorubicin (P < 0.03) reminiscent of the increased chemotherapy-associated necrosis seen in tumors with higher interstitial fluid pressure in the clinical study.

Conclusions: The results of this study suggest that cells in the in vivo pressurized environment are at a higher state of regenerative activity than is demonstrable in conventional cell culture systems. Variations in tumor interstitial fluid pressure have the potential to alter chemotherapeutic effects.

Key Words: Hydrostatic pressure • chemosensitivity • proliferation • osteosarcoma




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. H. Craig, B. Haimovich, and M. D. Basson
{alpha}-Actinin-1 phosphorylation modulates pressure-induced colon cancer cell adhesion through regulation of focal adhesion kinase-Src interaction
Am J Physiol Cell Physiol, December 1, 2007; 293(6): C1862 - C1874.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. R. DiResta, S. W. Aiken, H. K. Brown, P. J. Bergman, A. Hohenhaus, E. J. Ehrhart, K. Baer, and J. H. Healey
Use of an Artificial Lymphatic System During Carboplatin Infusion to Improve Canine Osteosarcoma Blood Flow and Clinical Response
Ann. Surg. Oncol., August 1, 2007; 14(8): 2411 - 2421.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.